Conclusions
Our findings suggest questions that might be addressed in a larger
study. It might be possible to restrict imaging investigation to women
who have both markers elevated, thereby saving resources. It also might
be possible to explore a lower cut off value for CA125. This would
improve the sensitivity of CA125 for ovarian cancer detection if
specificity could be maintained when a simultaneous low-range HE4
excluded ovarian malignancy.